About Visi.cx
VisiCX helps clinical laboratories train workers, confirm their skills and keep compliance records. Its first product, LabCX, uses hands-free wearable technology so staff can learn at the lab bench. The platform supports laboratory compliance reviews. The site also identifies EduCX as a health care education technology platform. VisiCX is developing additional tools for health care operations.
VisiCX is based in Joplin, Missouri, and currently focuses on U.S. health care organizations. April German is founder and chief executive officer; she also oversees quality assurance and health data compliance. Leitha Boutwell is chief operating officer. The leadership team combines clinical laboratory, health care software and enterprise software experience. Current products use cloud infrastructure intended for regulated health settings, but they do not process protected health information.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 9, 2026 | Oct 16, 2026amended Oct 16, 2026 | $242,339fully sold | 5 | $48,468 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Why Investors Backed Visi.cx
VisiCX sells operations software for clinical laboratories. The company treats staff training as both a compliance burden and an operating expense. Its investment case rests on applying health care and software experience to a costly workflow.
The problem it targets
VisiCX argues that health care organizations lose patient-care time to administrative work. In laboratories, it points to binders, spreadsheets and repeated competency checks as burdens on staff. It estimates that a regulatory deficiency can cost $500 to $2,000. The company attributes more than $40,000 in annual supply waste to errors. It places ineffective training at over 50 lost hours per worker each year.
What the product does
LabCX validates workers’ skills through hands-free assessments. It records completed training for regulatory reviews. Staff receive real-time expert guidance through a headset for instrument and procedure problems. Its collaboration feature connects bench workers with specialists. Data uses TLS 1.2 or later during transfer and AES-256 at rest. Accounts can use multifactor authentication.
Progress so far
VisiCX reports average cost savings of 27.9%. A case study with Valor Health found $4,900 of waste over three months. It projected that pattern would create a $19,600 annual loss. The work found failed quality-control procedures, unnecessary recalibrations and repeated troubleshooting. Those issues caused repeated testing and wasted laboratory supplies.
We wrote this summary from public statements by Visi.cx and its investors. It is not investment advice.
Leadership Team
Executive officers and directors listed on Visi.cx's Form D filed Oct 16, 2026.
